| |
| |
|
| Insider
Information: |
Lefebvre Eric |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
199,820 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
199,820 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tobira Therapeutics Inc |
TBRA |
|
|
0 |
|
0 |
Premium* |
|
|
Pliant Therapeutics, Inc. |
PLRX |
Chief Medical Officer |
2024-01-23 |
199,820 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
42,900 |
199,820 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-01-17 |
4 |
AS |
$17.23 |
$177,383 |
D/D |
(10,295) |
156,920 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-07-17 |
4 |
AS |
$18.01 |
$401,981 |
D/D |
(22,321) |
167,215 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
189,536 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• • – |
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
57,000 |
133,926 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• • – |
2023-01-23 |
4 |
AS |
$34.48 |
$2,327,630 |
D/D |
(67,500) |
76,926 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• • – |
2022-12-20 |
4 |
S |
$19.10 |
$207,968 |
D/D |
(10,887) |
144,426 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
21,876 |
155,313 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-10-25 |
4 |
AS |
$25.05 |
$125,241 |
D/D |
(5,000) |
133,437 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-07-11 |
4 |
AS |
$20.00 |
$60,000 |
D/D |
(3,000) |
138,436 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-06-18 |
4 |
AS |
$28.62 |
$360,821 |
D/D |
(12,500) |
137,080 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-03-18 |
4 |
AS |
$39.38 |
$492,678 |
D/D |
(12,500) |
149,580 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2020-12-18 |
4 |
AS |
$26.17 |
$331,752 |
D/D |
(12,500) |
162,080 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Medical OfficerOfficer |
• – – |
2020-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
174,580 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
